HMP LITE vs FORWARD 102

LITE is a research study app designed to help engage and retain participants within the LITE HIV prevention study. It will support the overall study’s goal of supporting participants’ PrEP (pre-exposure prophylaxis) adherence over time through sustained platform engagement, weekly messages highlighting key app features, a game-based economy that awards badges for activities and milestones within the app, and continued development of content and activities to ensure the platform remains dynamic and fresh. LITE is an adaptation of the app, HMP, which covers a range of health and lifestyle topics to support users’ diverse backgrounds and varying needs over time. HMP was created by Lisa Hightow-Weidman, MD, MPH, a public health scientist. The principal investigators for this study are Dr. Sybil Hosek at Cook County Health, Dr. Audrey French at Cook County Health and Dr. Lisa Hightow-Weidman at the Institute on Digital Health and Innovation at Florida State University’s College of Nursing.

This app is intended for use by participants in the FORWARD 102 study and requires an invitation and activation code from the study site to register. A Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of VX-880 in Subjects With Type 1 Diabetes With a Kidney Transplant. This study has been reviewed and approved by the appropriate regulatory body, e.g. Institutional Review Board (IRB) or Independent Ethics Committee (IEC). Key App Features: - Patient Onboarding – complete study app registration and education - Activities – complete scheduled or on-demand study tasks and assessments - Dashboard – review overall progress in the study and current activities - Resources – view study information in the Learn section of the app - Profile – manage account details and app settings - Notifications – receive in-app reminders - Telehealth – conduct scheduled virtual visits with your study site About THREAD: THREAD’s® purpose is to leverage its clinical research platform to enable studies for everyone, everywhere. The company’s uniquely combined clinical research technology and consulting services help life science organizations to design, operate, and scale next-generation research studies and electronic clinical outcome assessments (eCOA) programs for participants, sites, and study teams. Through its comprehensive platform and scientific expertise, THREAD empowers studies to be accessible, efficient, and centered on the patient.